# NeuroScale

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuroscale

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Latest round: Angel (Aug 28, 2026)
- Investors on record: 1

## About

Based in Shanghai, China, and founded in 2026 by Zhen Pan and Enming Song, WholeBrain Core Technology (Shanghai) Co., Ltd., trading as NeuroScale, specializes in the research and industrialization of flexible silicon-based CMOS brain-computer interface technologies, aiming to achieve both high-performance neural signal acquisition and long-term biocompatibility.
In August 2026, NeuroScale raised an Angel funding led by Fudan Innovation Centre.
The company develops flexible CMOS-based brain-computer interface technologies and neural interface solutions designed to improve signal collection capabilities while maintaining biological compatibility over extended periods.
The company is expected to generate revenue through the commercialization of its brain-computer interface technologies, neural interface products, and related industry applications.
The company aims to further advance the development and industrialization of flexible silicon-based CMOS brain-computer interface technologies and next-generation neural interface solutions.

## Funding rounds

- Angel, Aug 28, 2026 — Fudan Innovation Centre

## Investors

- Fudan Innovation Centre (https://capitalatlas.ai/funds/fudan-innovation-centre) — Angel